HIMS
Hims & Hers Health, Inc.
Latest price
As of Oct 26, 2026, 6:51 PM EDT · Market data by Massive
Market cap
$6.5B
Volume
5.7M
Previous close
$27.71
Day range
$27.22 – $27.94
Listed
Jan 21, 2021
Coverage
7 articles
Price performance
Recent trading
Newsroom
Latest HIMS coverage
Hims & Hers Stock Jumps on FDA Signals, but Regulatory Risks Still Loom for Investors
Hims & Hers (HIMS) extended its rally this week, surging for a second straight session as investors reacted to signals that U.S. regulators may take a more flexible approach toward certain peptide treatments.
Stock Market Today: Dow, S&P 500, Nasdaq Slip as Tech Pullback and Iran Truce Talks Weigh on Markets
Stocks edged lower on Thursday, losing early gains as a pullback in Big Tech dragged on major indexes and investors closely watched developments around a potential extension of the U.S.-Iran ceasefire.
Stock Market Today: Nasdaq Turns Higher as Oil Pulls Back From $100 Spike, Dow and S&P 500 Slip
U.S. stocks were mixed on Monday as investors digested volatile energy prices and ongoing geopolitical conflicts that have rattled global markets.
Hims & Hers Dives on FDA Crackdown, Sending Shockwaves Through Weight-Loss Drug Trade
Hims & Hers (HIMS) took a steep dive after U.S. regulators signaled an aggressive move against compounded versions of blockbuster weight-loss medicines, shaking investor confidence in one of the fastest-growing corners of digital health.
Hims & Hers Stock Plunges After Novo Nordisk Breakup: What Really Happened?
Hims & Hers Health saw its stock crash by over 35% in a matter of days after Novo Nordisk announced the termination of its short-lived partnership over the weight loss drug Wegovy.
Stock Market Today: Stocks Climb as Earnings Pour In, Auto Tariff Relief Hopes Boost Optimism
Stocks moved higher on Tuesday as investors digested a wave of corporate earnings and looked to the White House for signs of relief from burdensome auto tariffs.
Stock Market Today: Stock Market Sees Downturn Amid Tariff Worries and Rising Inflation Fears
As of midday Tuesday, US stocks struggled as all three major indices fell. Investor sentiment was weighed down by President Trump's tariff comments and worsening consumer confidence.